CorMedix Inc. to Report First Quarter 2018 Financi
Post# of 97
BERKELEY HEIGHTS, NJ / ACCESSWIRE / May 9, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its financial results for the first quarter ended March 31, 2018, after the market close, and will host a corporate update conference call on Tuesday, May 15, 2018, at 4:30pm Eastern Time.
Tuesday, May 15 at 4:30 pm Eastern Time
Domestic: 877-407-9124
International: 201-689-8584
Conference ID: 13679901
Webcast: http://www.investorcalendar.com/event/29615
Replays, Available through May 28:
Domestic: 877-481-4010
Replay PIN: 29615
Cormedix Inc (CRMD) Stock Research Links
CLICK TO --> JOIN US RIGHT HERE